GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 142 filers reported holding GOSSAMER BIO INC in Q1 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,388 | -79.0% | 7,451 | -63.8% | 0.00% | – |
| Q4 2022 | $44,627 | -82.2% | 20,566 | -2.0% | 0.00% | – |
| Q3 2022 | $251,000 | +67.3% | 20,976 | +17.2% | 0.00% | – |
| Q2 2022 | $150,000 | -3.8% | 17,901 | -0.7% | 0.00% | – |
| Q1 2022 | $156,000 | -21.6% | 18,027 | +2.7% | 0.00% | – |
| Q4 2021 | $199,000 | -11.6% | 17,553 | -1.6% | 0.00% | – |
| Q3 2021 | $225,000 | +257.1% | 17,838 | +127.5% | 0.00% | – |
| Q2 2021 | $63,000 | -20.3% | 7,841 | -7.4% | 0.00% | – |
| Q1 2021 | $79,000 | -6.0% | 8,465 | -2.4% | 0.00% | – |
| Q4 2020 | $84,000 | -21.5% | 8,677 | 0.0% | 0.00% | – |
| Q3 2020 | $107,000 | -18.9% | 8,677 | -14.3% | 0.00% | – |
| Q2 2020 | $132,000 | +83.3% | 10,121 | +42.0% | 0.00% | – |
| Q1 2020 | $72,000 | -48.9% | 7,127 | -21.5% | 0.00% | – |
| Q4 2019 | $141,000 | +2.9% | 9,079 | +11.8% | 0.00% | – |
| Q3 2019 | $137,000 | +42.7% | 8,123 | +87.9% | 0.00% | – |
| Q2 2019 | $96,000 | +152.6% | 4,324 | +147.5% | 0.00% | – |
| Q1 2019 | $38,000 | – | 1,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |